𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations

✍ Scribed by Formantici, Cristina; Orlandi, Rosaria; Ronchini, Chiara; Pilotti, Silvana; Ranzani, Guglielmina N.; Colnaghi, Maria I.; M�nard, Sylvie

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
166 KB
Volume
187
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

✦ Synopsis

Based on a previous finding that amplification of the c-erbB-2 oncogene and alteration of p53 are strongly associated in most aggressive breast tumours, the present study investigated whether microsatellite instability (MI) might also be associated with this tumour phenotype. Nine polymorphic microsatellite markers, including six dinucleotide, one trinucleotide, and two tetranucleotide repeats, were amplified from paired normal and tumour DNA samples of 15 breast tumours that overexpressed both c-erbB-2 and p53 and of 15 control breast tumours that overexpressed neither protein. All 30 breast tumours analysed exhibited a replication error-negative phenotype, with only one sample showing MI in one of the nine loci. This suggests that the genetic events underlying MI, which are critical in colorectal and gastric tumours, are not involved in the pathogenesis of c-erbB-2/p53 double-altered breast tumours and do not play a central role in breast tumour formation.

📜 SIMILAR VOLUMES

Differences in patterns of TP53 and KRAS
Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability
✍ Elizabeth M. Swisher; Stacia Peiffer-Schneider; David G. Mutch; Thomas J. Herzog 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

The correlation between tumor microsatellite instability (MSI) and the accumulation of mutations in KRAS2 and TP53 is uncertain. The authors evaluated the TP53 and KRAS2 genes for mutations in sporadic endometrial carcinomas with microsatellite instability (MSI) and matched MSI negative controls to

Correlation between p53, c-erbB-2, and t
Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
✍ Rudolph, Pierre; Olsson, H�kan; Bonatz, Gabriele; Ratjen, Virgo; Bolte, Hendrik; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 1 views

Various new prognostic indicators have been identified for mammary carcinomas, but the issue of their significance remains unsettled. The prognostic impact of p53, c-erbB-2, and topoisomerase II alpha expression was investigated in relation to standard prognostic factors for carcinomas of the breast

Rare mutations of p53, Ki-ras, and β-cat
Rare mutations of p53, Ki-ras, and β-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N′-N-nitrosoguanidine–induced rat stomach cancers
✍ Yoshikazu Hirayama; Kuniko Wakazono; Masami Yamamoto; Motoo Kitano; Masae Tatema 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Rat stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) have been widely used as a model for human stomach cancers of the differentiated type. However, there has been little information regarding their molecular basis. In this study, we examined the genetic alterations reported in